Statistics

Total Visits

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis43

Select a period of time:

Number of views in the range

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy vs. Adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis33

Views

Views
March 202515
April 202512
May 20250
June 20250
July 20256
August 20250
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong10
United States3
Brazil3
Angola1
Spain1
 

Top cities views

Views
Hong Kong10
Catanduva1
Charlotte1
Council Bluffs1
Louveira1
Luanda1
McKinney1
Volta Redonda1